WSTWest Pharmaceutical Services

$366.17+44% 1Y

$366.17

$230.7852 weeks$376.78

WST in its own filings

WST's filing record carries one kind of hard flag, each is shown beside the share of the whole market carrying the same one, because more than half of all companies carry at least one.

535

Events found in the filings · across 3,443 filings · the record starts in 1994

Hard flags: 1
Hard flags
Most recent filing: Jul 23, 2026
Most recent filing · Form 10-Q
Record starts: Apr 5, 1994
Record starts · the earliest filing Ryufin holds for this name

Details›

Next results filingsame week as a year ago: expected around Oct 22, 2026
Late periodic reporthistorical: 1998-03-31
Material impairment2 occurrences: 2007-12-17
SEC comment-letter activity13 occurrences: 2009-06-25

SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.

What the company said

The company's own words from its current reports to the SEC, newest first

Jul 23, 2026West Reports Second-Quarter 2026 Results.Earnings release · press release
Jul 14, 2026West Pharmaceutical Services, Inc. (the "Company") and Daikyo Seiko, Ltd. ("Daikyo") have entered into an Amended and Restated Technology Exchange and Crosslicense Agreement (the “Crosslicense Agreement”) as well as two Distributorship Agreements (the “Distributorship Agreements”) effective July 14, 2026 (the …Material agreement entered · Form 8-K
Jun 1, 2026On March 9, 2026, West Pharmaceutical Services, Inc. (the “Company”) filed a Current Report on Form 8-K announcing that Mr. Eric M. Green, President, Chief Executive Officer and Chair of the Board of Directors (the “Board”) of the Company, informed the Board on March 6, 2026 of his intent to retire from those …Director or officer change · Form 8-K
May 20, 2026As previously disclosed in the Original Report, the Company determined on May 7, 2026 that the Company had experienced a material cybersecurity attack, in which certain data was exfiltrated by an unauthorized party and certain systems were encrypted.Material cybersecurity incident · Form 8-K/A
May 11, 2026On May 7, 2026, West Pharmaceutical Services, Inc. (the “Company”) determined that the Company has experienced a material cybersecurity attack, in which certain data was exfiltrated by an unauthorized party and certain systems were encrypted.Material cybersecurity incident · Form 8-K
Apr 23, 2026West Reports First-Quarter 2026 Results.Earnings release · press release
Mar 9, 2026Today, March 9, 2026, West Pharmaceutical Services, Inc. (the “Company”) announced that Mr. Eric M. Green, President, Chief Executive Officer and Chair of the Board of Directors (the “Board) of the Company, informed the Board on March 6, 2026 of his intent to retire from those positions once his successor has been …Director or officer change · Form 8-K
Feb 12, 2026West Reports Fourth-Quarter and Full-Year 2025 Results.Earnings release · press release
Oct 23, 2025West Reports Third-Quarter 2025 Results.Earnings release · press release
Sep 11, 2025Today, September 11, 2025, West Pharmaceutical Services, Inc. (the “Company”) announced that Kimberly Banks MacKay, Senior Vice President, General Counsel, and Corporate Secretary, will be leaving the Company.Director or officer change · Form 8-K